Steven K. Lundy, Ph.D.

Steven K. Lundy, Ph.D. was a Research Associate Professor in the Department of Internal Medicine-Rheumatology at the University of Michigan Medical School from Fall 2016 to Spring 2019. Steve grew up in the small village of Rothschild in the central part of Wisconsin, and graduated from Escanaba Area Public High School in the upper peninsula of Michigan in 1983.

Steve earned his Bachelor of Science degree in Biochemistry from Oakland University, Auburn Hills, Michigan in 1987. He then worked in the Immunology Department at the Mayo Foundation in Rochester, Minnesota for six years as a Research Technician, followed by three years as a lab manager in Radiation Oncology at Wayne State University in Detroit, Michigan.

Steve then pursued his doctorate in the laboratory of Dov L. Boros, Ph.D. in the Department of Immunology and Microbiology at Wayne State University, graduating in 2001. His thesis was entitled "Mechanisms of CD4+ T cell apoptosis during murine Schistosoma mansoni infection". The major findings of his dissertation were that B cells, particularly CD5+ B-1a cells, in schistosome infected mice expressed Fas ligand and were able to kill activated T cells.

Dr. Lundy did his first post-doctoral fellowship in the lab of Nick Lukacs, Ph.D. in Pathology at the University of Michigan studying the role of T cells and B cells in the cockroach allergen-induced asthma model, and again found evidence that CD5+ B cells regulated T cell death and the severity of disease. His second post-doctoral fellowship was in the lab of David Fox, M.D. in Internal Medicine-Rheumatology at the University of Michigan, and is where he made the transition to faculty in 2006.

Steve had an active research lab within the Division of Rheumatology and has been a research mentor to several graduate and undergraduate students. He had R21, R03, and K01 grants from the National Institutes of Health that supported his basic research and several clinical collaborations funded by the Merck Corporation, Chugai Pharmaceuticals, and an Autoimmune Centers of Excellence grant from the NIH. Past sponsorship was also received from the Edward T. and Ellen K. Dryer Foundation,the Arthritis Foundation, the Michigan Diabetes Research and Training Center, and the Mary H. Weiser Food Allergy Center at the University of Michigan.

Dr. Lundy was an active participant in the Graduate Immunology Program of the Program in Biomedical Sciences first as a postdoctoral fellow and then as a faculty member until leaving the university in 2019. He had been a course coordinator and instructor for IMM850 Experimental Immunology. He also gave lectures in other courses in the Immunology Program as well as teaching first and second-year medical students in the University of Michigan Medical School. Steve has given basic immunology presentations to clinical fellows and faculty within the Division of Rheumatology and other units.

In February 2019, Dr. Lundy was forced to close his lab at the University of Michigan due to a lack of funding. He retained an affiliation with UM as an Adjunct Research Associate Professor and is currently a Principal Scientist in Immuno-Oncology at Systimmune Inc. in Redmond, Washington.